Guangzhou Wondfo Biotech Co Ltd (300482) — Strategic Asset Allocation Index
Guangzhou Wondfo Biotech Co Ltd (300482) has a Strategic Asset Allocation Index of 26.2% as of December 2022. Strategic assets (PP&E of CN¥1.19 Billion plus long-term investments of CN¥-) total CN¥1.19 Billion, measured against net assets of CN¥4.54 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Guangzhou Wondfo Biotech Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Guangzhou Wondfo Biotech Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Guangzhou Wondfo Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of December 2022, the index stands at 26.2%, representing strategic assets of CN¥1.19 Billion against net assets of CN¥4.54 Billion CNY. For live market cap and overall valuation, see 300482 company net worth.
Annual Strategic Asset Allocation Index for Guangzhou Wondfo Biotech Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Wondfo Biotech Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Guangzhou Wondfo Biotech Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.2% | CN¥1.19 Billion | CN¥1.19 Billion | CN¥- | CN¥4.54 Billion | ▲ +0.4 pp |
| 2021 | 25.9% | CN¥906.09 Million | CN¥906.09 Million | CN¥- | CN¥3.50 Billion | ▲ +3.3 pp |
| 2020 | 22.6% | CN¥676.63 Million | CN¥676.63 Million | CN¥- | CN¥2.99 Billion | ▲ +2.0 pp |
| 2019 | 20.6% | CN¥505.86 Million | CN¥505.86 Million | CN¥- | CN¥2.46 Billion | ▼ -6.6 pp |
| 2018 | 27.2% | CN¥584.50 Million | CN¥396.68 Million | CN¥187.82 Million | CN¥2.15 Billion | ▼ -5.0 pp |
| 2017 | 32.1% | CN¥382.54 Million | CN¥254.12 Million | CN¥128.41 Million | CN¥1.19 Billion | ▲ +5.2 pp |
| 2016 | 26.9% | CN¥230.01 Million | CN¥223.77 Million | CN¥6.24 Million | CN¥854.75 Million | ▼ -2.4 pp |
| 2015 | 29.3% | CN¥205.08 Million | CN¥151.18 Million | CN¥53.90 Million | CN¥700.64 Million | ▼ -17.5 pp |
| 2014 | 46.7% | CN¥146.49 Million | CN¥146.49 Million | CN¥- | CN¥313.43 Million | ▼ -9.8 pp |
| 2013 | 56.5% | CN¥136.44 Million | CN¥136.44 Million | CN¥- | CN¥241.47 Million | ▼ -13.4 pp |
| 2012 | 69.9% | CN¥127.52 Million | CN¥127.52 Million | CN¥- | CN¥182.48 Million | ▼ -6.5 pp |
| 2011 | 76.4% | CN¥110.48 Million | CN¥110.48 Million | CN¥- | CN¥144.61 Million | — |